Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2-Reference-Cited by-同舟云学术

Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2

Published:2022-10 Issue:4 Volume:41 Page:111508
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Kim Garam,Nakayama Lisa,Blum Jacob A.,Akiyama Tetsuya,Boeynaems Steven,Chakraborty Meenakshi,Couthouis Julien,Tassoni-Tsuchida Eduardo,Rodriguez Caitlin M.,Bassik Michael C.,Gitler Aaron D.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference39 articles.

1. Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans);Altman;N. Engl. J. Med.,1973

2. TDP-43 toxicity in yeast;Armakola;Methods,2011

3. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43;Arnold;Proc. Natl. Acad. Sci. USA,2013

4. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice;Becker;Nature,2017

5. Antisense drugs make sense for neurological diseases;Bennett;Annu. Rev. Pharmacol. Toxicol.,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities;Cells;2024-08-28

2. ATP6V1A is required for synaptic rearrangements and plasticity in murine hippocampal neurons;Acta Physiologica;2024-06-05

3. Structured and disordered regions of Ataxin-2 contribute differently to the specificity and efficiency of mRNP granule formation;PLOS Genetics;2024-05-20

4. Modeling sporadic juvenile ALS in iPSC-derived motor neurons explores the pathogenesis of FUSR503fs mutation;Frontiers in Cellular Neuroscience;2024-04-22

5. Rare association between spinocerebellar ataxia and amyotrophic lateral sclerosis: a case series;Neurological Sciences;2024-04-20